Instylla is a medical equipment supplier that provides liquid embolics of the next generation for interventional radiology.
Instylla has raised $21.7M in total funding. The most recent round was Series C. The last funding was announced in October 2025.
Instylla's investors include Ascension Ventures, Delos Capital, Catalyst Health Ventures, Excelestar Ventures, Sparta Group.
Instylla is headquartered in Waltham, United States.
Instylla is a medical equipment supplier that provides liquid embolics of the next generation for interventional radiology.
Instylla is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Instylla — Funding & Investors." VCBacked, October 17, 2025, https://www.vcbacked.co/company/instylla. Accessed August 14, 2026.
VCBacked. (2025). Instylla — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/instylla
{{cite web |title=Instylla — Funding & Investors |url=https://www.vcbacked.co/company/instylla |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated